Zyvox - News Articles

Evidence-based guidance issued for treating MRSA infections -- Jackson, 10.1542/aapnews.20110111-1 -- AAP News


The guideline discusses the use of linezolid as an acceptable alternative agent and daptomycin for the patient with invasive skeletal infection or endocarditis. Infectious disease consultation also is recommended if the patient fails to respond to therapy or has an isolate ...
The IN VIVO Blog: Financings of the Fortnight Will Sell No Wine Before Its Time


mainly to fund a 240-patient Phase 2b trial of its lead product delafloxacin against standards of care linezolid and vancomycin. The firm hoped to be in Phase III by now, but an overhaul of FDA guidelines for clinical endpoints ...
Jefferson Post - Focus on Medicaid fraud yields 53 million in 2010


paid illegal kickbacks and marketed drugs for unapproved uses in order to sell more of certain drugs, including Bextra, Geodon, Zyvox, and Lyrica. The MIU recovered nearly $1.9 million from a mental health provider in Fayetteville and Dunn that fabricated and forged ...
America’s Worst Directors: M. Anthony Burns Of Pfizer - 24/7 Wall St.


of off-label marketing of painkiller Bextra, which is now off the market, the psychiatric drug Geodon, antibiotic Zyvox and anti-epileptic drug Lyrica. It was the largest health care fraud settlement and the largest criminal fine of any kind ever. The board ...
Robert Langreth - Treatments - Forbes


Pfizer's Zyvox is one of the only new classes to combat such killers strains. In contrast, the peptide antibiotics are less vulnerable to resistance because they infiltrate and damage the membrane that holds the bacterium together. In 2000 DeGrado became curious about what was ...
The IN VIVO Blog: Let It Snow, Let It Snow, I-P-O


comparing its lead compound torezolid to Pfizer's standard-of-care for skin infections, Zyvox (linezolid), according to president and CEO Jeffrey Stein. But Trius had to settle for $50 million and one trial, and it will now look to sell some ...
FDA Advisory Committee Recommends Approval of Forest Laboratories' Ceftaroline Fosamil for the Treatment of Community Acquired Bacterial Pneumonia and Complicated Skin and Skin Structure Infections - MarketWatch


Ceftaroline has demonstrated antibacterial activity in vitro against vancomycin-resistant S. aureus (VRSA) and linezolid-resistant S. aureus. Ceftaroline is a member of the cephalosporin class of antibiotics, the most frequently prescribed class of antibiotics in the ...
FDA Advisory Committee Recommends Approval Of Forest Laboratories' Ceftaroline Fosamil For The Treatment Of Community Acquired Bacterial Pneumonia


Ceftaroline has demonstrated antibacterial activity in vitro against vancomycin-resistant S. aureus (VRSA) and linezolid-resistant S. aureus. Ceftaroline is a member of the cephalosporin class of antibiotics , the most frequently prescribed class of antibiotics in ...
Rib-X Pharmaceuticals Presents Data for Radezolid Demonstrating Positive Antibacterial Activity and Ability to Overcome Common Bacterial Resistance Mechanism | Business Wire


“We also confirmed, using our X-ray crystal structure analysis, that radezolid targets ribosomal binding sites that are uncovered by linezolid. These attributes offer several potential therapeutic benefits, including enhanced MRSA coverage and greater potency than linezolid with broader spectrum ...
Trius Therapeutics Initiates Phase 3 Program of Oral Torezolid Phosphate for the Treatment of ABSSSI - MarketWatch


days of treatment with the efficacy and safety of twice-daily oral administration of 600 milligrams of linezolid (Zyvox(R)) for 10 days of treatment. The enrollment of the first patient into this study, which is the first ABSSSI study initiated under a Special ...
Ops emphasis lets Pfizer extend product life - FiercePharma Manufacturing


Among such products produced in Portage are anti-inflammatory medicine Solu-Medrol, antibacterial treatment Zyvox and cancer treatment Camptosar. ...
PipelineReview.com - Biotech News & Online Store - Nabriva initiates Phase II of pleuromutilin antibiotic BC-3781


including MRSA, associated with skin infections and community and hospital acquired pneumonia and is more potent than Linezolid and vancomycin. The compound’s novel mode of action ensures that it overcomes resistance mechanisms affecting all approved classes of antibiotics. BC-3781 ...
Health News - Responsible Stewardship by Clinicians is Critical to Preventing Antibiotic Resistance


Linezolid is used to treat a variety of bacteria, including methiciliin-resistant S aureus (MRSA). Clinicians have not learned from previous issues with antibiotic resistance, and it is essential that they take the problem seriously, Gaynes says. For example, a ...
Login - :: Infectious Disease Special Edition ::


An outbreak of infection due to linezolid and methicillin-resistant Staphylococcus aureus (LRSA) in 12 intensive care unit patients in Spain was associated ...
? ?????????? ????????????? ???? ??????? ????????? ????????????? - ??????? ????? ( The Epoch Times ) - ?????????? ??????? ? ????????????? ?? ????? ????. ???????????? ??????? ?? ?????.


?????????? ? ??????? ????????? ? 2005 ????, ???????????????? Geodon, ?????????? Zyvox ? ????????? ?????? ?????????????? ????????? Lyrica. ...
?????????? ??????? ???????? : Dailymedi


?? ???? ??? ??? ??? ?? ?? ????? ???? ?? ??? ??? ???? 2000? ?? FDA ??? ?? ???? 'Zyvox'? ??? ??? ...
Media-Newswire.com - Press Release Distribution - PR Agency


Apoorv Kalra studies linezolid, an antibiotic made by Pfizer, and its impact on bacteria called Staphylococcus aureus, the most common cause of staph infections. Kalra's research program was selected by Pfizer for further funding. He focuses on linezolid's effect on the ...
The State News


Linezolid is developed by Pfizer. Kalra said he found out he won the award when some senior faculty members contacted him. “(They) called me and I was really surprised actually,” Kalra said. “This was my first grant application. It was exciting.” The award ...
Pediatric SuperSite - Error


Linezolid and daptomycin may be candidates to replace vancomycin as the primary therapy for methicillin-resistant Staphylococcus aureus, but evidence ...
Moguai lanseaza albumul de debut We are Lyve


Cele mai recente piese ale sale au aparut pe 12" si poarta numele de ZYVOX si Lyve/Impereal. Discul de debut, We are Lyve, a stat in productie foarte multi ani, si spera sa ii ridice profilul la un rang superior. Albumul este plin de varietati muzicale, ...
Want to contact a Zyvox attorney in District of Columbia?...Get a free case evaluation from one of our Zyvox attorneys in District of Columbia now.

Pages:   1   2   Next

Need A Zyvox Attorney?

First Name Last Name Email Address State
Has Your Health Been Negatively Affected?

Please Describe the Injury

Your Friend's Email Address

Your Email Address

Type a Message (optional)


Want to contact a Zyvox attorney in District of Columbia?...Get a free case evaluation from one of our Zyvox attorneys in District of Columbia now.

 

Close (x)

Looking for an Attorney?


Please type your question:

Close (x)

logo Find Legal Help for Your Zyvox Case - Submit Your Information Below

Do you need legal assistance with your Zyvox case?
LegalView may be able to help.


Submit your information below for a free, no-cost evaluation.

We'll submit your information to one of our partner firms.
LegalView's partners represent clients throughout the United States, for a very wide range of legal issues. Submit your information now, to see if one of LegalView's partners can help!

* Indicates Required Fields

First name *
Last name *
Email Address *
Phone Number *
()  -

State *
Legal Issue * DrugWatch: Zyvox Change
Was There an Injury?
Please Describe The Injury

DISCLAIMER and STATEMENT OF NON-CONFIDENTIALITY

By submitting this form, you agree that completing the above is not intended to create an attorney-client relationship.

Disclosure

Legal WebTV Network LLC, LegalView.com, and LegalWebMedia.com are group advertising sponsored by the attorneys identified here. It is not a lawyer referral service. If you submit information on this website [more...]

Legal WebTV Network LLC, LegalView.com, and LegalWebMedia.com are group advertising sponsored by the attorneys identified here. It is not a lawyer referral service. If you submit information on this website, LegalWebMedia.com will submit your information to the law firms that pay for this group advertising and to respond to your requests for information concerning legal services in their assigned local areas. If there is no sponsoring firm in your state, your inquiry will be submitted to one of the sponsoring law firms on a predetermined, rotating basis. If the sponsoring law firm accepts your case, it will associate with licensed attorneys practicing in your state, if required; the sponsoring law firm may also contact other law firms to see if they may be able to assist.

The information provided by the LegalView.com and LegalWebMedia.com websites is for advertising and informational purposes and should not be considered as legal advice from the sponsoring attorneys. The websites contain general information and may not reflect current legal developments, verdicts, or settlements. LegalView.com contains information created by others or supplied through open forums; the sponsoring law firms are not responsible for the accuracy of this information. Any person viewing or receiving information from these websites should not act or refrain from acting on the basis of any such information without first seeking appropriate legal advice from an attorney in your area. Legal WebTV Network, LLC expressly disclaims any liability with respect to actions taken or not taken by the recipient based on any or all of the information or contents contained in these websites.

Any information sent to Legal WebTV Network LLC through this website is done using standard Web encryption techology. LegalView.com will exercise all reasonable care, within technological limits, to protect the confidentiality of any information submitted via Internet e-mail or through this website. By accessing this website, you may be seeking an attorney to represent you or legal advice. However, none of the sponsoring attorneys represent you yet.

The choice of a lawyer is an important decision and should not be based solely upon advertisements.

Any transmission of information, whether via Internet e-mail or through the website, is solely for evaluation purposes by the sponsoring law firms and their associates. The transmission of any information to any attorney sponsoring advertising on LegalView.com or LegalWebMedia.com does not create an attorney-client relationship between the sender and any recipient. An attorney-client relationship can only be created by a written, signed-fee agreement entered into with an attorney. The sponsoring attorneys will treat your information as a confidential communication for the purpose of obtaining legal services or legal advice.

For more information about the sponsoring law firms, please click here.

This form is secure and encrypted. More information about secure forms and your privacy here.